Rising recalls, tighter FDA enforcement, global supply chain dependencies, and rapid technology shifts are reshaping pharmaceutical quality and compliance—forcing manufacturers to rethink oversight, ...
Two weeks after launch, 91% of people had confirmed that they had completed the training. That level of visibility simply wasn’t possible for us before.” — Daniel Burgess, Aerogen Pharma SAN MATEO, CA ...